Report cover image

Global Nuclear Medicine & Radiopharmaceuticals Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 104 Pages
SKU # APRC20340627

Description

Summary

According to APO Research, The global Nuclear Medicine & Radiopharmaceuticals market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Nuclear Medicine & Radiopharmaceuticals is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Nuclear Medicine & Radiopharmaceuticals is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Nuclear Medicine & Radiopharmaceuticals is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Nuclear Medicine & Radiopharmaceuticals include Aurobindo Pharma, Bracco Imaging, Cardinal Health, Curium Pharma, GE Healthcare, Jubilant Pharma, Lantheus, Mundipharma and SIEMENS, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine & Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine & Radiopharmaceuticals.

The Nuclear Medicine & Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Medicine & Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Nuclear Medicine & Radiopharmaceuticals Segment by Company

Aurobindo Pharma
Bracco Imaging
Cardinal Health
Curium Pharma
GE Healthcare
Jubilant Pharma
Lantheus
Mundipharma
SIEMENS
Bayer
Dongcheng
Eli Lilly
Novartis
China Isotope & Radiation
Nuclear Medicine & Radiopharmaceuticals Segment by Type

Diagnostic Radiopharmaceuticals
Therapeutic Radiopharmaceuticals
Nuclear Medicine & Radiopharmaceuticals Segment by Application

Oncology
Cardiology
Thyroid
Others
Nuclear Medicine & Radiopharmaceuticals Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine & Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine & Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine & Radiopharmaceuticals.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Medicine & Radiopharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Nuclear Medicine & Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

104 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Estimates and Forecasts (2020-2031)
1.3 Nuclear Medicine & Radiopharmaceuticals Market by Type
1.3.1 Diagnostic Radiopharmaceuticals
1.3.2 Therapeutic Radiopharmaceuticals
1.4 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Type
1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Overview by Type (2020-2031)
1.4.2 Global Nuclear Medicine & Radiopharmaceuticals Historic Market Size Review by Type (2020-2025)
1.4.3 Global Nuclear Medicine & Radiopharmaceuticals Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2020-2025)
1.5.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2020-2025)
1.5.4 South America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Nuclear Medicine & Radiopharmaceuticals Industry Trends
2.2 Nuclear Medicine & Radiopharmaceuticals Industry Drivers
2.3 Nuclear Medicine & Radiopharmaceuticals Industry Opportunities and Challenges
2.4 Nuclear Medicine & Radiopharmaceuticals Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Nuclear Medicine & Radiopharmaceuticals Revenue (2020-2025)
3.2 Global Top Players by Nuclear Medicine & Radiopharmaceuticals Sales (2020-2025)
3.3 Global Top Players by Nuclear Medicine & Radiopharmaceuticals Price (2020-2025)
3.4 Global Nuclear Medicine & Radiopharmaceuticals Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Nuclear Medicine & Radiopharmaceuticals Major Company Production Sites & Headquarters
3.6 Global Nuclear Medicine & Radiopharmaceuticals Company, Product Type & Application
3.7 Global Nuclear Medicine & Radiopharmaceuticals Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Nuclear Medicine & Radiopharmaceuticals Market CR5 and HHI
3.8.2 Global Top 5 and 10 Nuclear Medicine & Radiopharmaceuticals Players Market Share by Revenue in 2024
3.8.3 2023 Nuclear Medicine & Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
4 Nuclear Medicine & Radiopharmaceuticals Regional Status and Outlook
4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Nuclear Medicine & Radiopharmaceuticals Historic Market Size by Region
4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Region (2020-2025)
4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Sales in Value by Region (2020-2025)
4.2.3 Global Nuclear Medicine & Radiopharmaceuticals Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Nuclear Medicine & Radiopharmaceuticals Forecasted Market Size by Region
4.3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Region (2026-2031)
4.3.2 Global Nuclear Medicine & Radiopharmaceuticals Sales in Value by Region (2026-2031)
4.3.3 Global Nuclear Medicine & Radiopharmaceuticals Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Nuclear Medicine & Radiopharmaceuticals by Application
5.1 Nuclear Medicine & Radiopharmaceuticals Market by Application
5.1.1 Oncology
5.1.2 Cardiology
5.1.3 Thyroid
5.1.4 Others
5.2 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Application
5.2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Overview by Application (2020-2031)
5.2.2 Global Nuclear Medicine & Radiopharmaceuticals Historic Market Size Review by Application (2020-2025)
5.2.3 Global Nuclear Medicine & Radiopharmaceuticals Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application (2020-2025)
5.3.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application (2020-2025)
5.3.4 South America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Aurobindo Pharma
6.1.1 Aurobindo Pharma Comapny Information
6.1.2 Aurobindo Pharma Business Overview
6.1.3 Aurobindo Pharma Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Aurobindo Pharma Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.1.5 Aurobindo Pharma Recent Developments
6.2 Bracco Imaging
6.2.1 Bracco Imaging Comapny Information
6.2.2 Bracco Imaging Business Overview
6.2.3 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.2.5 Bracco Imaging Recent Developments
6.3 Cardinal Health
6.3.1 Cardinal Health Comapny Information
6.3.2 Cardinal Health Business Overview
6.3.3 Cardinal Health Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Cardinal Health Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.3.5 Cardinal Health Recent Developments
6.4 Curium Pharma
6.4.1 Curium Pharma Comapny Information
6.4.2 Curium Pharma Business Overview
6.4.3 Curium Pharma Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Curium Pharma Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.4.5 Curium Pharma Recent Developments
6.5 GE Healthcare
6.5.1 GE Healthcare Comapny Information
6.5.2 GE Healthcare Business Overview
6.5.3 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.5.5 GE Healthcare Recent Developments
6.6 Jubilant Pharma
6.6.1 Jubilant Pharma Comapny Information
6.6.2 Jubilant Pharma Business Overview
6.6.3 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.6.5 Jubilant Pharma Recent Developments
6.7 Lantheus
6.7.1 Lantheus Comapny Information
6.7.2 Lantheus Business Overview
6.7.3 Lantheus Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Lantheus Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.7.5 Lantheus Recent Developments
6.8 Mundipharma
6.8.1 Mundipharma Comapny Information
6.8.2 Mundipharma Business Overview
6.8.3 Mundipharma Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mundipharma Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.8.5 Mundipharma Recent Developments
6.9 SIEMENS
6.9.1 SIEMENS Comapny Information
6.9.2 SIEMENS Business Overview
6.9.3 SIEMENS Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.9.4 SIEMENS Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.9.5 SIEMENS Recent Developments
6.10 Bayer
6.10.1 Bayer Comapny Information
6.10.2 Bayer Business Overview
6.10.3 Bayer Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bayer Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.10.5 Bayer Recent Developments
6.11 Dongcheng
6.11.1 Dongcheng Comapny Information
6.11.2 Dongcheng Business Overview
6.11.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.11.5 Dongcheng Recent Developments
6.12 Eli Lilly
6.12.1 Eli Lilly Comapny Information
6.12.2 Eli Lilly Business Overview
6.12.3 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.12.5 Eli Lilly Recent Developments
6.13 Novartis
6.13.1 Novartis Comapny Information
6.13.2 Novartis Business Overview
6.13.3 Novartis Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Novartis Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.13.5 Novartis Recent Developments
6.14 China Isotope & Radiation
6.14.1 China Isotope & Radiation Comapny Information
6.14.2 China Isotope & Radiation Business Overview
6.14.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.14.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.14.5 China Isotope & Radiation Recent Developments
7 North America by Country
7.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country
7.1.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2020-2025)
7.1.3 North America Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2026-2031)
7.2 North America Nuclear Medicine & Radiopharmaceuticals Market Size by Country
7.2.1 North America Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Nuclear Medicine & Radiopharmaceuticals Market Size by Country (2020-2025)
7.2.3 North America Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country
8.1.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2020-2025)
8.1.3 Europe Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2026-2031)
8.2 Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Country
8.2.1 Europe Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Country (2020-2025)
8.2.3 Europe Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Country
9.1.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Country (2020-2025)
9.1.3 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size by Country
9.2.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Nuclear Medicine & Radiopharmaceuticals Sales by Country
10.1.1 South America Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2020-2025)
10.1.3 South America Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2026-2031)
10.2 South America Nuclear Medicine & Radiopharmaceuticals Market Size by Country
10.2.1 South America Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Nuclear Medicine & Radiopharmaceuticals Market Size by Country (2020-2025)
10.2.3 South America Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country
11.1.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2020-2025)
11.1.3 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size by Country
11.2.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Nuclear Medicine & Radiopharmaceuticals Value Chain Analysis
12.1.1 Nuclear Medicine & Radiopharmaceuticals Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Nuclear Medicine & Radiopharmaceuticals Production Mode & Process
12.2 Nuclear Medicine & Radiopharmaceuticals Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Nuclear Medicine & Radiopharmaceuticals Distributors
12.2.3 Nuclear Medicine & Radiopharmaceuticals Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.